Laura Maria Schreiber

Laura Maria Schreiber

Auto-generated profile, based on publicly available information

Laura Maria Schreiber

Department of Cardiovascular Imaging and Chair of Molecular and Cellular Imaging, Comprehensive Heart Failure Center Wuerzburg (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2020 in Nature Reviews Cardiology
Verified
Journal Article
Open access
PDF file
OGon behalf of the Quantitative Cardiac Imaging Study Group
on behalf of the Quantitative Cardiac Imaging Study Group
MDMarc Dewey
Marc Dewey
MSMaria Siebes
Maria Siebes
MKMarc Kachelrieß
Marc Kachelrieß
KKKlaus F. Kofoed
Klaus F. Kofoed
LSLaura Schreiber
Laura Schreiber
Cardiac imaging has a pivotal role in the prevention, diagnosis and treatment of ischaemic heart disease. SPECT is most commonly used for clinical myocardial perfusion imaging, whereas PET is the clinical reference standard for the quantification of myocardial perfusion. MRI does not involve exposure to ionizing radiation, similar to echocardiography, which can be performed at the bedside. CT perfusion imaging is not frequently used but CT offers coronary angiography data, and invasive catheter-based methods can measure coronary flow and pressure. Technical improvements to the quantification of pathophysiological parameters of myocardial ischaemia can be achieved. Clinical consensus recommendations on the appropriateness of each technique were derived following a European quantitative cardiac imaging meeting and using a real-time Delphi process. SPECT using new detectors allows the quantification of myocardial blood flow and is now also suited to patients with a high BMI. PET is well suited to patients with multivessel disease to confirm or exclude balanced ischaemia. MRI allows the evaluation of patients with complex disease who would benefit from imaging of function and fibrosis in addition to perfusion. Echocardiography remains the preferred technique for assessing ischaemia in bedside situations, whereas CT has the greatest value for combined quantification of stenosis and characterization of atherosclerosis in relation to myocardial ischaemia. In patients with a high probability of needing invasive treatment, invasive coronary flow and pressure measurement is well suited to guide treatment decisions. In this Consensus Statement, we summarize the strengths and weaknesses as well as the future technological potential of each imaging modality.

17 May 2010 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
TSThomas D. Schladt
Thomas D. Schladt
MSMohammed Ibrahim Shukoor
Mohammed Ibrahim Shukoor
KSKerstin Schneider
Kerstin Schneider
MTMuhammad Nawaz Tahir
Muhammad Nawaz Tahir
FNFilipe Natalio
Filipe Natalio
WTWolfgang Tremel
Wolfgang Tremel

4 April 2023 in Medical Image Analysis
Verified
Journal Article
Closed access
LLLei Li
Lei Li
FWFuping Wu
Fuping Wu
SWSihan Wang
Sihan Wang
Xinzhe LuoXinzhe Luo
Xinzhe Luo
CMCarlos Martín-Isla
Carlos Martín-Isla
Xiahai ZhuangXiahai Zhuang
Xiahai Zhuang

18 June 2009 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
EBE. J. R. van Beek
E. J. R. van Beek
ADA. M. Dahmen
A. M. Dahmen
TST. Stavngaard
T. Stavngaard
KGK. K. Gast
K. K. Gast
CHC. P. Heussel
C. P. Heussel
HKH-U. Kauczor
H-U. Kauczor
The aim of the present study was to apply hyperpolarised (HP)3He magnetic resonance imaging (MRI) to identify patients with chronic obstructive pulmonary disease (COPD) and α1-antitrypsin deficiency (α1-ATD) from healthy volunteers and compare HP3He MRI findings with high-resolution computed tomography (HRCT) in a multicentre study. Quantitative measurements of HP3He MRI (apparent diffusion coefficient (ADC)) and HRCT (mean lung density (MLD)) were correlated with pulmonary function tests.A prospective three centre study enrolled 122 subjects with COPD (either acquired or genetic) and age-matched never-smokers. All diagnostic studies were completed in 94 subjects (52 with COPD; 13 with α1-ATD; 29 healthy subjects; 63 males; and 31 females; median age 62 yrs). The consensus assessment of radiologists, blinded for other test results, estimated nonventilated lung volume (HP3He MRI) and percentage diseased lung (HRCT). Quantitative evaluation of all data for each centre consisted of ADC (HP3He MRI) and MLD measurements (HRCT), and correlation with forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) indicating airway obstruction, and the diffusing capacity of the lung for carbon monoxide (DL,CO) indicating alveolar destruction.Using lung function tests as a reference, regional analysis of HP3He MRI and HRCT correctly categorised normal volunteers in 100% and 97%, COPD in 42% and 69% and α1-ATD in 69% and 85% of cases, respectively. Direct comparison of HP3He MRI and CT revealed 23% of subjects with moderate/severe structural abnormalities had only mild ventilation defects. In comparison with lung function tests, ADC was more effective in separating COPD patients from healthy subjects than MLD (p<0.001versus0.038). ADC measurements showed better correlation withDL,COthan MLD (r = 0.59versus0.29).Hyperpolarised3He MRI correctly categorised patients with COPD and normal volunteers. It offers additional functional information, without the use of ionising radiation whereas HRCT gives better morphological information. We showed the feasibility of a multicentre study using different magnetic resonance systems.

5 March 2012 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
GBGrzegorz Bauman
Grzegorz Bauman
ASAlexander Scholz
Alexander Scholz
JRJulien Rivoire
Julien Rivoire
MTMaxim Terekhov
Maxim Terekhov
JFJanet Friedrich
Janet Friedrich
MPMichael Puderbach
Michael Puderbach

27 August 2010 in Journal of Materials Chemistry
Verified
Journal Article
Closed access
PDF file
TSThomas D. Schladt
Thomas D. Schladt
KSKerstin Schneider
Kerstin Schneider
MSM. Ibrahim Shukoor
M. Ibrahim Shukoor
FNFilipe Natalio
Filipe Natalio
HBHeiko Bauer
Heiko Bauer
WTWolfgang Tremel
Wolfgang Tremel
Superparamagnetic MnO nanoparticles were functionalized using a hydrophilic ligand containing protoporphyrin IX as photosensitizer. By virtue of their magnetic properties these nanoparticles may serve as contrast enhancing agents for magnetic resonance imaging (MRI), while the fluorescent target ligand protoporphyrin IX allows simultaneous tumor detection and treatment by photodynamic therapy (PDT). Caki-1 cells were incubated with these nanoparticles. Subsequent exposure to UV light lead to cell apoptosis due to photoactivation of the photosensitizer conjugated to the nanoparticles. This method offers great diagnostic potential for highly proliferative tissues, including tumors. In addition, it is an efficient platform that combines the advantages of a biocompatible photosensitizer with the possibility for MRI monitoring due to the magnetic properties of the highly soluble functionalized manganese oxide nanoparticles.